I always thought platform was the best route but I think the move away from internal candidates says a lot ? too hard basket again ? - they couldn't really bring attractive data packs up despite extending the time frame a couple of times ? The long long elusive pk/pd remains the way it has for years elusive ? I think it's all a bit in the air chop changing lead focus (again) - have swapped between internal candidates and delivery how many times now ?
Interesting year ahead I just hope they sell something in 2018 and it doesn't end with them going back to yet again another new (or old) strategy.
Ann: Phylogica Strategic Update - Pivot to Platform, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $398.2K | 313.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15688 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 12441 | 2 |
View Market Depth
| Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |